SymBio Pharmaceuticals Limited
Monthly status of exercise of the 58th and 66th stock acquisition rights issued through third-party allocation (with exercise price adjustment clause)
Disclosure of the monthly exercise status of stock acquisition rights issued via third-party allocation. Includes a detailed table defining exercised shares, exercise amount, issued shares, and other items constituting the exercise status. Monitoring future exercise trends and dilution impact is important.
Key Figures
- Exercised shares: Unknown
- Exercise price: Unknown
- Issued shares: Unknown
AI要約
Section Heading
This disclosure reports the monthly status of exercise for the 58th and 66th stock acquisition rights (with exercise price adjustment clause) issued via third-party allocation. The body lists the number of issued shares, exercised shares, exercise amounts, per-date exercise status, and decimal rounding details in a tabular format. While not directly linked to financial indicators, it contains information important for assessing dilution prospects.
Section 2 Heading
The document presents both monthly aggregate exercise values and daily details, implying that future exercise trends could affect issued shares and dilution. In particular, attention should be paid to changes in issued shares, the number of rights, and the exercise amounts at each exercise event. It remains important to continue tracking applicable terms (e.g., exercise price adjustment clauses).
SymBio Pharmaceuticals Limited
Company overview · Stock price · Financial data · All IR
